Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBRAIN

MR Contrast Media in Neuroimaging: A Critical Review of the Literature

Jonathan Breslau, Jeffrey G. Jarvik, David R. Haynor, W. T. Longstreth Jr, Daniel L. Kent and Kenneth R. Maravilla
American Journal of Neuroradiology April 1999, 20 (4) 670-675;

Appendix — Articles reviewed:

  1. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-60
    PubMedWeb of Science
  2. Allen ED, Byrd SE, Darling CF, Tomita T, Wilczynski MA. The clinical and radiological evaluation of primary brain neoplasms in children, part II: radiological evaluation. J Natl Med Assoc 1993;85:546-553
    PubMed
  3. Aslanian V, Lemaignen H, Bunouf P, Svaland MG, Borseth A, Lundby B. Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective. Neuroradiology 1996;38:537-541
    PubMed
  4. Baierl P, Muhlsteffen A, Haustein J, et al. Comparison of plain and Gd-DTPA–enhanced MR-imaging in children. Pediatr Radiol 1990;20:515-519
    CrossRefPubMedWeb of Science
  5. Baleriaux D, Matos C, DeGreef D. Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA. Neuroradiology 1993;35:490-494
    CrossRefPubMed
  6. Ball WSJ, Parker JR, Davis PC, Glasier CM, Morris MR. Efficacy of gadoteridol for contrast-enhanced magnetic resonance imaging in children. Invest Radiol 1992;27:S45-S52
  7. Ball WSJ, Nadel SN, Zimmerman RA, et al. Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease. Radiology 1993;186:769-774
    PubMed
  8. Bauer WM, Fenzl G, Vogl T, Fink U, Lissner J. Indications for the use of Gd-DTPA in MRI of the central nervous system: experiences in patients with cerebral and spinal diseases. Invest Radiol 1988;23(Suppl):S286-S288
  9. Burke JW, Podrasky AE, Bradley WG. Meninges: benign postoperative enhancement on MR images. Radiology 1990;174:99-102
    PubMed
  10. Carvlin MJ, DeSimone DN, Meeks MJ. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent. Invest Radiol 1992;27:S16-S21
  11. Chong VFH, Fan Y, Khoo JBK. Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J Comput Assist Tomogr 1996;20:563-569
    CrossRefPubMedWeb of Science
  12. Davis PC, Hudgins PA, Peterman SB, Hoffman JCJ. Diagnosis of cerebral metastases: double-dose delayed CT vs. contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991;12:293-300
    Abstract/FREE Full Text
  13. Debatin JF, Nadel SN, Gray L, et al. Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging. Pediatr Radiol 1992;10:101-108
  14. DeSimone D, Morris M, Rhoda C, et al. Evaluation of the safety and efficacy of gadoteridol injection (a low osmolal magnetic resonance contrast agent): clinical trials report. Invest Radiol 1991;26:S212-S216
  15. Deutsch AL, Howard M, Dawson EG. Lumbar spine following successful surgical discectomy: magnetic resonance imaging features and implications. Spine 1993;18:1054-1060
    CrossRefPubMed
  16. Ekholm S, Jonsson E, Sandvik L, et al. Tolerance and efficacy of omniscan (gadodiamide injection) in MR imaging of the central nervous system. Acta Radiol 1996;37:223-228
    PubMed
  17. Eldevik OP, Brunberg JA. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age. AJNR Am J Neuroradiol 1994;15:1001-1008
    Abstract/FREE Full Text
  18. Elster AD, Rieser GD. Gd-DTPA–enhanced cranial MR imaging in children: initial clinical experience and recommendations for its use. AJR Am J Roentgenol 1989;153:1265-1268
    PubMedWeb of Science
  19. Elster AD, Moody DM, Ball MR, Laster DW. Is Gd-DTPA required for routine cranial MR imaging? Radiology 1989;173:231-238
    PubMedWeb of Science
  20. Elster AD, DiPersio DA. Cranial postoperative site: assessment with contrast-enhanced MR imaging. Radiology 1990;174:93-98
    PubMedWeb of Science
  21. Elster AD, Moody DM. Early cerebral infarction: gadopentetate dimeglumine enhancement. Radiology 1990;177:627-632
    PubMedWeb of Science
  22. Elster AD. MR contrast enhancement in brainstem and deep cerebral infarction. AJNR Am J Neuroradiol 1991;12:1127-1132
    Abstract/FREE Full Text
  23. Elster AD, Mirza W. MR imaging in chronic partial epilepsy: role of contrast enhancement. AJNR Am J Neuroradiol 1991;12:165-170
    Abstract/FREE Full Text
  24. Fazekas F, Fazekas G, Schmidt R, Kapeller P, Offenbacher H. Magnetic resonance imaging correlates of transient ischemic attacks. Stroke 1996;27:607-611
    Abstract/FREE Full Text
  25. Felix R, Schorner W, Laniado M, et al. Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985;156:681-688
    PubMedWeb of Science
  26. Filling-Katz MR, Choyke PL, Patronas NJ, et al. Radiologic screening for vonHippel-Lindau disease: the role of Gd-DTPA enhanced MR imaging of the CNS. J Comput Assist Tomogr 1989;13:743-755
    PubMed
  27. Filling-Katz MR, Choyke PL, Oldfield E, et al. Central nervous system involvement in vonHippel-Lindau disease. Neurology 1991;41:41-46
    Abstract/FREE Full Text
  28. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MSB, Barkovich AJ. Radiological classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 1996;24:9-23
    PubMedWeb of Science
  29. Frank JA, Bash C, Stone L, Petrella J, Maloni H, McFarland H. . Acad Radiol 1996;3:S173-S175
  30. Ge HL, Hirsch WL, Wolf GL, Rubin RA, Hackett RK. Diagnostic role of gadolinium-DTPA in pediatric neuroradiology: a retrospective review of 655 cases. Neuroradiology 1992;34:122-125
    PubMed
  31. Grane P, Tullberg T, Rydberg J, Lindgren L. Postoperative lumbar MR imaging with contrast enhancement: comparison between symptomatic and asymptomatic patients. Acta Radiol 1996;37:366-372
    PubMedWeb of Science
  32. Greco A, McNamara MT, Lanthiez P, Quay SC, Michelozzi G. Gadodiamide injection: nonionic gadolinium chelate for MR imaging in the brain and spine: phase II–III clinical trial. Radiology 1990;176:451-456
    PubMed
  33. Haughton VM, Rimm AA, Czervionke LF, et al. Sensitivity of Gd-DTPA–enhanced MR imaging of benign extraaxial tumors. Radiology 1988;166:829-833
    PubMedWeb of Science
  34. Haustein J, Laniado M, Niendorf HP, et al. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. AJNR Am J Neuroradiol 1992;13:1199-1206
    Abstract/FREE Full Text
  35. Haustein J, Laniado M, Niendorf HP, et al. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Radiology 1993;186:855-860
    PubMedWeb of Science
  36. Hesselink JR, Dunn WM, Healy ME, Hajek P, Baker L, Brahme FJ. Paramegnetic enhancement of cerebral lesions with gadolinium-DTPA. Acta Radiol Suppl Stockh 1986;369:558-560
  37. Hesselink JR, Healy ME, Press GA, Brahme FJ. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities. J Comput Assist Tomogr 1988;12:266-274
    PubMedWeb of Science
  38. Hudgins PA, Davis PC, Hoffman JCJ. Gadopentetate dimeglumine-enhanced MR imaging in children following surgery for brain tumor: spectrum of meningeal findings. AJNR Am J Neuroradiol 1991;12:301-307
    Abstract/FREE Full Text
  39. Hueftle MG, Modic MT, Ross JS, et al. Lumbar spine: postoperative MR imaging with Gd-DTPA. Radiology 1988;167:817-824
    PubMed
  40. Jackler RK, Shapiro MS, Dillon WP, Pitts L, Lanser MJ. Gadolinium-DTPA enhanced magnetic resonance imaging in acoustic neuroma diagnosis and management. Otolaryngol Head Neck Surg 1990;102:670-677
    PubMedWeb of Science
  41. Jinkins JR, Osborn AG, Garrett DJ, Hunt S, Story JL. Spinal nerve enhancement with Gd-DTPA: MR correlation with the postoperative lumbosacral spine. AJNR Am J Neuroradiol 1993;14:383-394
    Abstract/FREE Full Text
  42. Kaplan GD, Aisen AM, Aravapalli SR. Preliminary clinical trial of gadodiamide injection: a new nonionic gadolinium contrast agent for MR imaging. J Magn Reson Imaging 1991;1:57-62
    PubMed
  43. Kilgore DP, Breger RK, Daniels DL, Pojunas KW, Williams AL, Haughton VM. Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA. Radiology 1986;160:757-761
    PubMedWeb of Science
  44. Kucharczyk W, Lee DH, McClarty B, Robertson WD, Hele MJ. Routine contrast enhancement for cranial magnetic resonance imaging: an analysis of its diagnostic value in adults. Can Assoc Radiol J 1991;42:199-209
    PubMed
  45. Lundby B, Gordon P, Hugo F. MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications. Eur J Radiol 1996;23:190-196
    CrossRefPubMed
  46. Martin N, Sterkers O, Nahum H. Chronic inflammatory disease of the middle ear cavities: Gd-DTPA–enhanced MR imaging. Radiology 1990;176:399-405
    PubMedWeb of Science
  47. Menor F, Marti BL, Mulas F, Poyatos C, Cortina H. Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients. Pediatr Radiol 1992;22:485-489
    CrossRefPubMedWeb of Science
  48. Meyers SP, Wildenhain S, Chess MA, Tarr RW. Postoperative evaluation for intracranial recurrence if medulloblastoma: MR findings with gadopentetate dimeglumine. AJNR Am J Neuroradiol 1994;15:1425-1434
    Abstract/FREE Full Text
  49. Moghrabi A, Kerby T, Tien RD, Friedman HS. Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas. Pediatr Neurosurg 1995;23:293-298
    CrossRefPubMedWeb of Science
  50. Morikawa M, Sato S, Numaguchi Y, Mihara F, Rothman MI. Spinal epidural venous plexus: its MR enhancement patterns and their clinical significance. Radiat Med 1996;14:221-227
    PubMed
  51. Muller W, Kramer G, Roder RG, Kuhnert A. Balance of T1-weighted images before and after application of a paramagnetic substance (Gd-DTPA). Neurosurg Rev 1987;10:117-122
    PubMed
  52. Myhr G, Rinck PA, Borseth A. Gadodiamide injection and gadopentetate dimeglumine: a double-blind study in MR imaging of the CNS. Acta Radiol 1992;33:405-409
    PubMed
  53. Nelson DR, Yuh WT, Waziri MH, et al. MR imaging of Hippel-Lindau disease: value of gadopentetate dimeglumine. J Magn Reson Imaging 1991;1:469-476
    PubMed
  54. Niendorf HP, Felix R, Laniado M, Schorner W, Kornmesser W, Claussen C. Magnetic resonance imaging of intracranial tumors using gadolinium-DTPA: initial experience with fast imaging. Acta Radiol Suppl Stockh 1986;369:561-563
  55. Nishimura R, Takahashi M, Morishita S, Sumi M, Uozumi H, Sakamoto Y. MR Gd-DTPA enhancement of radiation brain injury. Radiat Med 1992;10:109-116
    PubMed
  56. Nishimura R, Takahashi M, Morishita S, Sumi M, Uozumi H, Sakamoto Y. MR imaging of late radiation brain injury. Radiat Med 1992;10:101-108
    PubMed
  57. Parizel PM, Baleriaux D, Rodesch G, et al. Gd-DTPA–enhanced MR imaging of spinal tumors. AJR Am J Roentgenol 1989;152:1087-1096
    PubMed
  58. Parizel PM, Degryse HR, Gheuens J, et al. Gadolinium-DOTA enhanced MR imaging of intracranial lesions. J Comput Assist Tomogr 1989;13:378-385
    CrossRefPubMed
  59. Post MJ, Sze G, Quencer RM, Eismont FJ, Green BA, Gahbauer H. Gadolinium-enhanced MR in spinal infection. J Comput Assist Tomogr 1990;14:721-729
    PubMedWeb of Science
  60. Powers TA, Partain CL, Kessler RM, et al. Central nervous system lesions in pediatric patients: Gd-DTPA–enhanced MR imaging. Radiology 1988;169:723-726
    PubMedWeb of Science
  61. Quint DJ, Eldevik OP, Cohen JK. Magnetic resonance imaging of normal meningeal enhancement at 1.5 T. Acad Radiol 1996;2:463-468
  62. Rahmouni A, Divine M, Mathieu D, et al. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 1993;160:1049-1052
    PubMed
  63. Robinson DA, Steiner RE, Young IR. The MR contribution after CT demonstration of supratentorial mass effect without additional localising features. J Comput Assist Tomogr 1988;12:275-279
    PubMed
  64. Rollins N, Mendelsohn D, Mulne A, et al. Recurrent medulloblastoma: frequency of tumor enhancement on Gd-DTPA MR imaging. AJR Am J Roentgenol 1990;155:153-157
    PubMed
  65. Ross JS, Modic MT, Masaryk TJ. Tears of the anulus fibrosus: assessment with Gd-DTPA–enhanced MR imaging. AJNR Am J Neuroradiol 1989;10:1251-1254
    Abstract/FREE Full Text
  66. Ross JS, Masaryk TJ, Schrader M, Gentili A, Bohlman H, Modic MT. MR imaging of the postoperative lumbar spine: assessment with gadopentetate dimeglumine. AJNR Am J Neuroradiol 1990;11:771-776
    Abstract/FREE Full Text
  67. Ross JS, Modic MT, Masaryk TJ, Carter J, Marcus RE, Bohlman H. Assessment of extradural degenerative disease with Gd-DTPA–enhanced MG imaging: correlation with surgical and pathological findings. AJR Am J Roentgenol 1990;154:151-157
    PubMed
  68. Runge VM, Schaible TF, Goldstein HA, et al. Gd DTPA: clinical efficacy. Radiographics 1988;8:147-159
    PubMed
  69. Runge VM, Bradley WG, Brant-Zawadzki M, et al. Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease. Radiology 1991;181:701-709
    PubMed
  70. Runge VM, Dean B, Lee C, Carolan F, Heard G. Phase III clinical evaluation of Gd-HP-DO3A in head and spine disease. J Magn Reson Imaging 1991;1:47-56
    PubMed
  71. Runge VM, Bronen RA, Davis KR. Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine. Invest Radiol 1992;27:522-532
  72. Russell EJ, Schaible TF, Dillon W, et al. Multicenter double-blind placebo-controlled study of gadopentetate as an MR contrast agent: evaluation in patients with cerebral lesions. AJR Am J Roentgenol 1989;152:813-823
    PubMed
  73. Sanders WP, Silbergleit R, Spickler EM, Barkley GL, Mehta BA. Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination. Invest Radiol 1995;30:634-637
    PubMed
  74. Sartoretti-Schefer Idiopathic, herpetic and HIV-associated facial nerve palsies: abnormal MR enhancement patterns. AJNR Am J Neuroradiol 1994;15:479-485
    Abstract/FREE Full Text
  75. Schorner W, Schubeus P, Henkes H, Lanksch W, Felix R. “Meningeal sign”: a characteristic finding of meningiomas on contrast-enhanced MR images. Neuroradiology 1990;32:90-93
    PubMed
  76. Schroth G, Grodd W, Guhl L, Grauer M, Klose U, Niendorf HP. Magnetic resonance imaging in small lesions of the central nervous system: improvement by gadolinium-DTPA. Acta Radiol 1987;28:667-672
    PubMedWeb of Science
  77. Schubeus P, Schorner W, Haustein J. Dosing of Gd-DTPA in MR imaging of intracranial tumors. Magn Reson Med 1991;22:249-254
    PubMed
  78. Schwaighofer BW, Klein MV, Wesbey G, Hesselink JR. Clinical experience with routine Gd-DTPA administration for MR imaging of the brain. J Comput Assist Tomogr 1990;14:11-17
    PubMed
  79. Seiderer M. Phase III clinical studies with gadoteridol for the evaluation of neurologic pathology: a European perspective. Invest Radiol 1992;27:533-538
  80. Sharif HS, Clark DC, Aabed MY, et al. Granulomatous spinal infections: MR imaging. Radiology 1990;177:101-107
    PubMedWeb of Science
  81. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJR Am J Roentgenol 1990;155:1293-1301
    PubMedWeb of Science
  82. Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma. AJR Am J Roentgenol 1996;167:1029-1036
    PubMedWeb of Science
  83. Stabler A, Bellan M, Weiss M, Grtner C, Brossman J, Reiser MF. MR imaging of enhancing intraosseous disk herniation (Schmorl's nodes). AJR Am J Roentgenol 1997;168:933-938
    PubMedWeb of Science
  84. Stack JP, Antoun NM, Jenkins JP, Metcalfe R, Isherwood J. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain. Neuroradiology 1988;30:145-154
    CrossRefPubMedWeb of Science
  85. Stack JP, Ransden RT, Antoun NM, Lye RH, Isherwood J, Jenkins JP. Magnetic resonance imaging of acoustic neuromas: the role of gadolinium-DTPA. Br J Radiol 1988;61:800-805
    Abstract/FREE Full Text
  86. Sze G, Krol G, Zimmerman RD, Deck MD. Intramedullary disease of the spine: diagnosis using gadolinium-DTPA-enhanced MR imaging. AJR Am J Roentgenol 1988;151:1193-1204
    CrossRefPubMed
  87. Sze G, Soletsky S, Bronen R, Krol G. MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. AJNR Am J Neuroradiol 1989;10:965-975
    Abstract/FREE Full Text
  88. Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 1990;11:785-791
    Abstract/FREE Full Text
  89. Sze G, Brant-Zawadzki M, Haughton VM, et al. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991;181:693-699
    PubMed
  90. Sze G, Brant-Zawadzki M, McNamara MT, et al. Use of the magnetic resonance contrast agent gadodiamide in the central nervous system: results of a multicenter trial. Invest Radiol 1993;28:S49-S55
  91. Tam JK, Bradley WG, Goergen SK, et al. Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium. Radiology 1996;198:273-278
    PubMed
  92. Tas MW, Barkhol F, van Walderveen MAA, Polman CH, Hommes OR, Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 1995;16:259-264
    Abstract/FREE Full Text
  93. Tuite M, Ketonen L, Kieburtz K, Handy B. Efficacy of gadolinium in MR brain imaging of HIV-infected patients. AJNR Am J Neuroradiol 1993;14:257-263
    Abstract/FREE Full Text
  94. Tullberg T, Grane P, Isacson J. Gadolinium-enhanced magnetic resonance imaging of 36 patients one year after lumbar disc resection. Spine 1994;19:176-182
    PubMedWeb of Science
  95. Tullberg T, Grane P, Rydberg J, Isacson J. Comparison of contrast-enhanced computed tomography and gadolinium-enhanced magnetic resonance imaging one year after lumbar discectomy. Spine 1994;19:183-188
    PubMed
  96. Valk J, De SRG, Crezee FC, Hazenberg GJ, Thjaha SI. Gadolinium-DTPA in magnetic resonance imaging of the brain. Neurosurg Rev 1987;10:87-92
    PubMed
  97. Valk J, De SRG, Crezee FC, Hazenberg GJ, Thjaha SI, Nauta JJ. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA. Acta Radiol 1987;28:659-665
    PubMedWeb of Science
  98. Valk J, Algra PR, Hazenberg GJ, Slooff WB, Svaland MG. A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system. Neuroradiology 1993;35:173-177
    CrossRefPubMed
  99. Weingarten K, Ernst RJ, Jahre C, Zimmerman RD. Detection of residual or recurrent meningioma after surgery: value of enhanced vs. unenhanced MR imaging. AJR Am J Roentgenol 1992;158:645-650
    PubMedWeb of Science
  100. Wiebe S, Lee DH, Karlik SJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992;32:643-650
    CrossRefPubMedWeb of Science
  101. Yousem DM, Patrone PM, Grossman RI. Leptomeningeal metastases: MR evaluation. J Comput Assist Tomogr 1990;14:255-261
    PubMedWeb of Science
  102. Yuh WT, Crain MR, Loes DJ, Greene GM, Ryals TJ, Sato Y. MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR Am J Neuroradiol 1991;12:621-629
    Abstract/FREE Full Text
  103. Yuh WT, Fisher DJ, Engelken JD, et al. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 1991;180:485-491
    PubMed
  104. Yuh WT, Engelken JD, Muhonen MG, Mayr NA, Fisher DJ, Ehrhardt JC. Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. AJNR Am J Neuroradiol 1992;13:335-345
    Abstract/FREE Full Text
  105. Yuh WT. Delineation of gliomas with various doses of MR contrast material. AJNR Am J Neuroradiol 1994;15:983-989
    Abstract/FREE Full Text
  106. Yuh WT. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. AJNR Am J Neuroradiol 1994;15:1037-1051
    Abstract/FREE Full Text
  107. Zee CS, Segall HD, Destian S, Ahmadi J, Apuzzo ML. MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr 1993;17:932-939
    PubMed
  108. Zimmerman RA, Bilaniuk LT, Rebsamen S. Magnetic resonance imaging of pediatric posterior fossa tumors. Pediatr Neurosurg 1992;18:58-64
    PubMedWeb of Science
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
MR Contrast Media in Neuroimaging: A Critical Review of the Literature
Jonathan Breslau, Jeffrey G. Jarvik, David R. Haynor, W. T. Longstreth Jr, Daniel L. Kent, Kenneth R. Maravilla
American Journal of Neuroradiology Apr 1999, 20 (4) 670-675;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement